Polymorphisms of thrombophilia genes with some visceral signs of connective tissue dysplasia


DOI: https://dx.doi.org/10.18565/therapy.2020.6.46-51

Yagoda A.V., Airapetian L.A.

Stavropol State Medical University of the Ministry of Healthcare of Russia
The aim of the study: to establish the relationship between some developmental anomalies and dysplastic-dependent lesions of the gall bladder (GB), kidneys in young patients with connective tissue dysplasia and polymorphisms of genes (regulators of blood coagulation, platelet aggregation and homocysteine metabolism).
Material and methods. Data on the study of polymorphisms of 12 genes of the hemostasis system (blood coagulation factors, platelet receptor glycoproteins, regulator genes for homocysteine metabolism) in young people (Slavs) with connective tissue dysplasia and in control individuals was investigated.
Results and conclusion. A burdened family history of thrombosis and hemorrhage in first-line relatives was encountered with abnormalities and dysplastic-dependent changes in the GB and urinary system (US) more often than in the general group of patients with DST. The presence of an association of the constriction of the gallbladder with the A allele, genotypes A/A and G/A of the FII gene: 20210G/A (prothrombin) is proved. In the group with JB anomalies, the frequency of occurrence of integrin gene polymorphisms, ITGA2-α2: 807С / Т and ITGВ-3β: 1565Т / С, controlling platelet receptors for collagen and fibrinogen, was determined to be relatively higher than in the absence of anomalies. A reliable relationship between nephroptosis and genotypes A/A and G/A of the FGB gene: -455G / A (fibrinogen) and an increase in US anomalies as compared to controlling the frequency of its heterozygotes were shown. In case of anomalies of the urinary system, the incidence of heterozygotes in the total fraction of the studied folate cycle genes was found to be lower than in cases without anomalies.

Literature



  1. Земцовский Э.В., Малев Э.Г. Малые аномалии сердца и диспластические фенотипы. СПб.: Изд-во «ИВЭСЭП». 2012. [Zemtsovskiy E.V., Malev E.G. Minor abnormalities of the heart and dysplastic phenotypes. St. Petersburg: IWESEP; 2012. (In Russ.)].

  2. Рудой А.С., Бова А.А., Нехайчик Т.А. Генетические аортопатии и структурные аномалии сердца. М.: ГЭОТАР-Медиа, 2017. [Rudoy A.S., Bova A.A., Nekhaychik T.A. Genetic aortopathies and structural anomalies of the heart. Moscow: GEOTAR-Media. 2017. (In Russ.)].

  3. Нечаева Г.И., Мартынов А.И. Дисплазия соединительной ткани: сердечно-сосудистые изменения, современные подходы к диагностике и лечению. Москва: ООО «Медицинское информационное агентство». 2017. [Nechaeva G.I., Martynov A.I. Connective tissue dysplasia: cardiovascular changes, modern approaches to diagnosis and treatment. Moscow: Meditsinskoe informatsionnoe agentstvo. 2017. (In Russ.)].

  4. Drossman D.A. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006; 30: 1377–90. doi: 10.1053/j.gastro.2006.03.008

  5. Нечаева Г.И., Лялюкова Е.А., Рожкова М.Ю. Дисплазия соединительной ткани: основные гастроэнтерологические проявления. Экспериментальная и клиническая гастроэнтерология. 2010; 6: 66–69. [Nechaeva G.I., Lyalyukova E.A., Rozhkova M.Yu. Connective tissue dysplasia: main gastroenterological manifestations. Eksperimental'naya i klinicheskaya gastroenterologiya. 2010; 6; 66–69 (In Russ.)].

  6. Нечаева Г.И., Логинова Е.Н., Цуканов А.Ю. с соавт. Патология почек при дисплазии соединительной ткани: междисциплинарный подход. Лечащий врач. 2016; 1: 54–57. [Nechaeva G.I., Loginova E.N., Tsukanov A.Yu. et al.Kidney pathology in connective tissue dysplasia: a multidisciplinary approach. Attending physician. 2016; 1: 54–57 (In Russ.)].

  7. Латышев Д.Ю., Текутьева Н.А., Лобанов Ю.Ф. с соавт. Дисплазия соединительной ткани и нервно-мышечная дисфункция мочевого пузыря у детей (обзор литературы). Нефрология. 2016; 20 (2): 39–47. [Latyshev D.Y., Tekutyeva N.A., Lobanov Y.F. et al. Connective tissue dysplasia and neuromuscular dysfunction of the urinary bladder in children (literature review). Nefrologiya. 2016; 20 (2): 39–47 (In Russ.)].

  8. Инзель Т.Н., Гаглоева Л.М., Ковальский С.В. Диагностическое значение специфических генотипических маркеров аномалий развития почек, ассоциированных с синдромом дисплазии соединительной ткани. Урология. 2000; 3: 8–9. [Inzel T.N., Gagloeva L.M., Kovalsky S.V. Diagnostic significance of specific genotypic markers of kidneys abnormal development, associated with connective tissue dysplasia syndrome. Urologiya. 2000; 3: 8–9 (In Russ.)].

  9. Баркаган З.С., Суханова Г.А., Буевич Е.И., Белых В.И. Геморрагические мезенхимальные дисплазии: основные нарушения в системе гемостаза и принципы их коррекции. Консилиум. 2000; 16(6): 6–11. [Barkagan Z.S., Sukhanova G.A., Buyevich Ye.I., Belykh V.I. Hemorrhagic mesenchymal dysplasia: the main disorders in the hemostatic system and the principles of their correction. Сonsilium. 2000; 16(6): 6–11. (In Russ.)].

  10. Суханова Г.А., Баркаган З.С., Котовщикова Е.Ф. с соавт. Тромботические мезенхимальные дисплазии и их связь с другими тромбофилиями. Гематология и трансфузиология. 2003; 6: 13–14. [Sukhanova G.A., Barkagan Z.S., Kotovshchikova Ye.F. et al. Thrombotic mesenchymal dysplasia and their relationship with other thrombophilia. Hematology and Transfusiology. 2003; 6: 13–14 (In Russ.)].

  11. Домницкая Т.М. Аномально расположенные хорды сердца. М.: ИД Медпрактика-М. 2008. [Domnitskaja T.M. Abnormally located heart tendons. M.: Medpraktika-M. 2008 (In Russ.)].

  12. Ягода А.В., Айрапетян Л.А. Генетические аспекты нарушений гемостаза при малых аномалиях сердца. Медицинский вестник Северного Кавказа. 2020; 15 (1): 46–52. [Yagoda A.V., Airapetian L.A. Genetic aspects of hemostasis disorders with small heart anomalies. Meditsinsky vestnik Severnogo Kavkaza. 2020; 15(1): 46–52 (In Russ.)]. doi: https://doi.org/10.14300/ mnnc.2020.15010.

  13. Гладких Н.Н., Ягода А.В. Клинико-патогенетические аспекты изменений в системе гемостаза при врожденной дисплазии соединительной ткани. Гематология и трансфузиология. 2007; 52(3): 42–47. [Gladkikh N.N., Yagoda A.V. Clinical and pathogenetic aspects of changes in the hemostatic system in congenital connective tissue dysplasia. Gematologiya i transfusiologiya. 2007; 52(3): 42–47 (In Russ.)].

  14. Неймарк А.И., Сибуль И.Э., Таранина Т.С. Морфологические изменения и нарушения гемостаза как проявление мезенхимальной дисплазии у больных нефроптозом. Урология и нефрология. 1998; 1: 29–31. [Neymark A.I., Sibul I.E., Taranina T.S. Morphological changes and hemostasis disorders as a manifestation of mesenchymal dysplasia in patients with nephroptosis. Urologiya i nefrologiya. 1998; 1: 29–31 (In Russ.)].

  15. Фирсова Л.В., Стуров В.Г., Ковынев И.Б. Нарушения конечного этапа свертывания крови у детей с синдромом гематомезенхимальной дисплазии и патология гемостаза у хирургических пациентов. Вестник молодого ученого. 2014; 3–4: 27–33. [Firsova L.V., Sturov V.G., Kovynev I.B. Disorders of the final stage of blood coagulation in children with hematomesenchymal dysplasia syndrome and hemostatic pathology in surgical patients. Vestnik molodogo uchyonogo. 2014; 3–4: 27–33 (In Russ.)].

  16. Фирсова Л.В., Стуров В.Г., Ковынев И.Б. Дисфункция конечного звена гемостаза у детей с соединительнотканной дисплазией и хирургическими заболеваниями. Вестник Новосибирского государственного университета. Серия: Биология, клиническая медицина. 2015; 13(4): 88–95. [Firsova L.V., Sturov V.G., Kovynev I.B. Dysfunction of the final link of hemostasis in children with connective tissue dysplasia and surgical diseases. Vestnik Novosibirskogo gosudarstvennogo universiteta (Series: Biologiya, klinicheskaya meditsina). 2015; 13(4): 88–95. (In Russ.)].

  17. Гематология: национальное руководство. Под ред. О.А. Рукавицына. М.: ГЭОТАР-Медиа. 2019. [Hematology: National guide. Ed. by. Rukavitsyna O.A. M.: GEOTAR-Media. 2019 (In Russ.)].

  18. Пизова Н.В. Тромбофилии: генетические полиморфизмы и сосудистые катастрофы. М.: ИМА-ПРЕСС, 2013. [Рizova N.V. Thrombophilia: genetic polymorphisms and vascular disaster. M.: IMA-PRESS. 2013 (In Russ.)].

  19. Li C., Ren H., Chen H. Prothrombin G20210A (rs1799963) polymorphism increases myocardial infarction risk in an age-related manner: A systematic review and meta-analysis. Scientific Reports. 2017; 7(1): 135–50. doi: 10.1038/s41598-017-13623-6.

  20. Girolami A., Cosi E., Ferrari S., Girolami В. Prothrombin: Another сlotting factor after FV that is involved both in bleeding and thrombosis. Clinical and Applied Thrombosis/Hemostasis. 2018; 24(6): 845–49.doi: 10.1177/1076029618770741.

  21. Wu G., Xi Y., Yao Y. et al. Genetic polymorphism of ITGA2 C807T can increase the risk of ischemic stroke. The International Journal of Neuroscience. 2014; 124: 841–51. doi:10.3109/00207454.2013.879718.

  22. Lu J.X., Lu Z.Q., Zhanq S.L. et al. Polymorphism in integrin ITGA2 is associated with ischemic stroke and altered serum cholesterol in chinese individuals. Balkan Medical Journal. 2014; 31: 55–59. doi: 10.5152/balkanmedj.2013.7993.

  23. Floyd C.N., Mustafa А., Ferro A. The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for myocardial infarction: a meta-analysis. PLoS ONE. 2014; 9 (7):1015–18. doi:10.1371/journal.pone.0101518.

  24. Todinova S., Komsa-Penkova R., Krumova S. et al. PlA2 Polymorphism in glycoprotein IIb/IIIa modulates the morphology and nanomechanics of platelets. Clinical and Applied Thrombosis/Hemostasis. 2017; 23(8): 951–60. doi: 10.1177/1076029616687847.

  25. Wu G., Cai H., Cai H. et al. Effect of the -148C/T, 448G/A, and -854G/A polymorphisms of the β-fibrinogen gene on the risk of ischemic stroke in Chinese population. Journal of Stroke and Cerebrovascular Diseases. 2015; 24: 1577–90. dоi: 10.1016/j.jstrokecerebrovasdis.2015.03.029.

  26. Mehlig K., Leander K., de Faire U. et al. The association between plasma homocysteine and coronary heart disease is modified by the MTHFR 677C>T polymorphism. Heart. 2013; 99(23): 1761–65.doi: 10.1136/heartjnl-2013-304460.

  27. Kim J.W., Jeon Y.J., Jang M.J. et al. Association between folate metabolism-related polymorphisms and colorectal cancer risk. Molecular and clinical oncology. 2015; 3: 639–48. doi: 10.3892/mco.2015.520.


About the Autors


Alexander V. Yagoda, MD, professor, head of Department of hospital therapy of Stavropol State medical University of the Ministry of Healthcare of Russia, honored worker of science of the Russian Federation. Address: 355017, Stavropol, 310 Mira str. Tel.: + 7 (8652) 29-53-09. E-mail: аlexander.yagoda@gmail.com. ORCID: 0000-0002-5727-1640
Lidia A. Airapetian, cardiologist, applicant of the Department of hospital therapy of Stavropol State medical University of the Ministry of Healthcare of Russia. Address: 355017, Stavropol, 310 Mira str. Tel.: + 7 (909) 773-59-08. E-mail: lidia13011991@gmail.com


Similar Articles


Бионика Медиа